KIG
BEAM icon

Kessler Investment Group’s Beam Therapeutics BEAM Stock Holding History

Kessler Investment Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,740
Closed -$83K – 155
2022
Q3 		$83K Buy
+1,740
New +$99.3K 0.07% 86
2022
Q2 		– Sell
-1,005
Closed -$58K – 173
2022
Q1 		$58K Buy
+1,005
New +$65.9K 0.03% 100

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Kessler Investment Group's BEAM Position: Q4 2022 in Review

Kessler Investment Group sold out of Beam Therapeutics (BEAM) in Q4 2022, closing a stake of 1,740 shares — an estimated $83K sold.

Kessler Investment Group first reported a position in BEAM in Q1 2022 and held it in 2 quarters. The position peaked at $83K in Q3 2022. 209 funds tracked by Wall St. Rank hold BEAM as of Q4 2022.

  • Kessler Investment Group reported no remaining Beam Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Kessler Investment Group sold 1,740 Beam Therapeutics shares in Q4 2022, an estimated $83K.
  • Kessler Investment Group first reported a position in Beam Therapeutics in Q1 2022 and held it in 2 quarters.
  • Kessler Investment Group's Beam Therapeutics position peaked at $83K in Q3 2022.
  • 209 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2022.

Based on Kessler Investment Group's 13F filing for Q4 2022, filed 31 Jan 2023.